This website is intended exclusively for the healthcare professionals residing and/or working in Thailand.

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Please log in or register to continue reading.

Science at Sanofi

Filter

Therapeutical Areas

From Risk Scores to Better Survival: Navigating the Future of Pulmonary Embolism Management

From Risk to Recurrence: Clinical Truths from the RIETE Registry on VTE Outcomes

How to screen for Gaucher disease among thalassemia patients?

How to Differentiate Gaucher Disease Type 1 vs Type 3

Exploring Gla-300 use in individuals with renal impairment

Anti-coagulant treatment of cancer-associated thrombosis in frail patients

Find your answer to help adults with insufficiently controlled T2D get to target HbA1c^2-6

Discover outcomes seen after starting Gla-300 in people with inadequately controlled T2DM on prior GLP-1 RA

Cancer-Associated VTE: Balancing Recurrence, Bleeding, and Clinical Risk

FRC vs Premix insulin: Key Study Findings

Thai Clinical Practice Guideline for the use of Nirsevimab

Safeguard your whole family Standard dose for child & adult & High-dose vaccine for seniors 65+

Login For Healthcare Professionals / เข้าสู่ระบบสำหรับผู้เชี่ยวชาญด้านสุขภาพ

HCP Verification Required

Email Verification Sent

Verify Email Required

Restricted Content

Register and stay ahead of the curve! กรุณาลงทะเบียนเพื่อรับข้อมูลข่าวสาร!

Areas of Interest

Consents

You are almost set!

Success

Welcome to Sanofi Campus

Empower TMS Video_Final

Science at Sanofi

Filter

Therapeutical Areas

From Risk Scores to Better Survival: Navigating the Future of Pulmonary Embolism Management

From Risk to Recurrence: Clinical Truths from the RIETE Registry on VTE Outcomes

How to screen for Gaucher disease among thalassemia patients?

How to Differentiate Gaucher Disease Type 1 vs Type 3

Exploring Gla-300 use in individuals with renal impairment

Anti-coagulant treatment of cancer-associated thrombosis in frail patients

Find your answer to help adults with insufficiently controlled T2D get to target HbA1c2-6

Discover outcomes seen after starting Gla-300 in people with inadequately controlled T2DM on prior GLP-1 RA

Cancer-Associated VTE: Balancing Recurrence, Bleeding, and Clinical Risk

FRC vs Premix insulin: Key Study Findings

Thai Clinical Practice Guideline for the use of Nirsevimab

Safeguard your whole family Standard dose for child & adult & High-dose vaccine for seniors 65+

Consents

Find your answer to help adults with insufficiently controlled T2D get to target HbA1c^2-6